
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Distinct evolution and dynamics of epigenetic and genetic heterogeneity in acute myeloid leukemia
Sheng Li, Francine E. Garrett-Bakelman, Stephen S. Chung, et al.
Nature Medicine (2016) Vol. 22, Iss. 7, pp. 792-799
Open Access | Times Cited: 351
Sheng Li, Francine E. Garrett-Bakelman, Stephen S. Chung, et al.
Nature Medicine (2016) Vol. 22, Iss. 7, pp. 792-799
Open Access | Times Cited: 351
Showing 1-25 of 351 citing articles:
The N6-methyladenosine (m6A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells
Ly Vu, Brian F. Pickering, Yuanming Cheng, et al.
Nature Medicine (2017) Vol. 23, Iss. 11, pp. 1369-1376
Open Access | Times Cited: 1077
Ly Vu, Brian F. Pickering, Yuanming Cheng, et al.
Nature Medicine (2017) Vol. 23, Iss. 11, pp. 1369-1376
Open Access | Times Cited: 1077
Scaling single-cell genomics from phenomenology to mechanism
Amos Tanay, Aviv Regev
Nature (2017) Vol. 541, Iss. 7637, pp. 331-338
Open Access | Times Cited: 767
Amos Tanay, Aviv Regev
Nature (2017) Vol. 541, Iss. 7637, pp. 331-338
Open Access | Times Cited: 767
The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions
Hamid Bolouri, Jason E. Farrar, Timothy J. Triche, et al.
Nature Medicine (2017) Vol. 24, Iss. 1, pp. 103-112
Open Access | Times Cited: 691
Hamid Bolouri, Jason E. Farrar, Timothy J. Triche, et al.
Nature Medicine (2017) Vol. 24, Iss. 1, pp. 103-112
Open Access | Times Cited: 691
Intratumoral heterogeneity in cancer progression and response to immunotherapy
Ilio Vitale, Efrat Shema, Sherene Loi, et al.
Nature Medicine (2021) Vol. 27, Iss. 2, pp. 212-224
Closed Access | Times Cited: 578
Ilio Vitale, Efrat Shema, Sherene Loi, et al.
Nature Medicine (2021) Vol. 27, Iss. 2, pp. 212-224
Closed Access | Times Cited: 578
The Key Role of Epigenetics in Human Disease Prevention and Mitigation
Andrew P. Feinberg
New England Journal of Medicine (2018) Vol. 378, Iss. 14, pp. 1323-1334
Closed Access | Times Cited: 520
Andrew P. Feinberg
New England Journal of Medicine (2018) Vol. 378, Iss. 14, pp. 1323-1334
Closed Access | Times Cited: 520
Non-genetic mechanisms of therapeutic resistance in cancer
Jean‐Christophe Marine, Sarah‐Jane Dawson, Mark A. Dawson
Nature reviews. Cancer (2020) Vol. 20, Iss. 12, pp. 743-756
Closed Access | Times Cited: 445
Jean‐Christophe Marine, Sarah‐Jane Dawson, Mark A. Dawson
Nature reviews. Cancer (2020) Vol. 20, Iss. 12, pp. 743-756
Closed Access | Times Cited: 445
Canonical and non-canonical WNT signaling in cancer stem cells and their niches: Cellular heterogeneity, omics reprogramming, targeted therapy and tumor plasticity (Review)
Masaru Katoh
International Journal of Oncology (2017) Vol. 51, Iss. 5, pp. 1357-1369
Open Access | Times Cited: 396
Masaru Katoh
International Journal of Oncology (2017) Vol. 51, Iss. 5, pp. 1357-1369
Open Access | Times Cited: 396
Oral Azacitidine Maintenance Therapy for Acute Myeloid Leukemia in First Remission
Andrew H. Wei, Hartmut Döhner, Christopher Pocock, et al.
New England Journal of Medicine (2020) Vol. 383, Iss. 26, pp. 2526-2537
Open Access | Times Cited: 336
Andrew H. Wei, Hartmut Döhner, Christopher Pocock, et al.
New England Journal of Medicine (2020) Vol. 383, Iss. 26, pp. 2526-2537
Open Access | Times Cited: 336
Immune signature drives leukemia escape and relapse after hematopoietic cell transplantation
Cristina Toffalori, Laura Zito, Valentina Gambacorta, et al.
Nature Medicine (2019) Vol. 25, Iss. 4, pp. 603-611
Closed Access | Times Cited: 329
Cristina Toffalori, Laura Zito, Valentina Gambacorta, et al.
Nature Medicine (2019) Vol. 25, Iss. 4, pp. 603-611
Closed Access | Times Cited: 329
Integrating genetic and non-genetic determinants of cancer evolution by single-cell multi-omics
Anna S. Nam, Ronan Chaligné, Dan A. Landau
Nature Reviews Genetics (2020) Vol. 22, Iss. 1, pp. 3-18
Open Access | Times Cited: 312
Anna S. Nam, Ronan Chaligné, Dan A. Landau
Nature Reviews Genetics (2020) Vol. 22, Iss. 1, pp. 3-18
Open Access | Times Cited: 312
BCAT1 restricts αKG levels in AML stem cells leading to IDHmut-like DNA hypermethylation
Simon Raffel, Mattia Falcone, Niclas Kneisel, et al.
Nature (2017) Vol. 551, Iss. 7680, pp. 384-388
Closed Access | Times Cited: 301
Simon Raffel, Mattia Falcone, Niclas Kneisel, et al.
Nature (2017) Vol. 551, Iss. 7680, pp. 384-388
Closed Access | Times Cited: 301
Single-cell entropy for accurate estimation of differentiation potency from a cell’s transcriptome
Andrew E. Teschendorff, Tariq Enver
Nature Communications (2017) Vol. 8, Iss. 1
Open Access | Times Cited: 296
Andrew E. Teschendorff, Tariq Enver
Nature Communications (2017) Vol. 8, Iss. 1
Open Access | Times Cited: 296
RnBeads 2.0: comprehensive analysis of DNA methylation data
Fabian Müller, Michael Scherer, Yassen Assenov, et al.
Genome biology (2019) Vol. 20, Iss. 1
Open Access | Times Cited: 277
Fabian Müller, Michael Scherer, Yassen Assenov, et al.
Genome biology (2019) Vol. 20, Iss. 1
Open Access | Times Cited: 277
Statistical and integrative system-level analysis of DNA methylation data
Andrew E. Teschendorff, Caroline L. Relton
Nature Reviews Genetics (2017) Vol. 19, Iss. 3, pp. 129-147
Open Access | Times Cited: 272
Andrew E. Teschendorff, Caroline L. Relton
Nature Reviews Genetics (2017) Vol. 19, Iss. 3, pp. 129-147
Open Access | Times Cited: 272
The leukaemia stem cell: similarities, differences and clinical prospects in CML and AML
David Vetrie, G. Vignir Helgason, Mhairi Copland
Nature reviews. Cancer (2020) Vol. 20, Iss. 3, pp. 158-173
Open Access | Times Cited: 266
David Vetrie, G. Vignir Helgason, Mhairi Copland
Nature reviews. Cancer (2020) Vol. 20, Iss. 3, pp. 158-173
Open Access | Times Cited: 266
Intratumor and Intertumor Heterogeneity in Melanoma
Tomasz M. Grzywa, Wiktor Paskal, Paweł Włodarski
Translational Oncology (2017) Vol. 10, Iss. 6, pp. 956-975
Open Access | Times Cited: 262
Tomasz M. Grzywa, Wiktor Paskal, Paweł Włodarski
Translational Oncology (2017) Vol. 10, Iss. 6, pp. 956-975
Open Access | Times Cited: 262
The DNA methylation landscape of glioblastoma disease progression shows extensive heterogeneity in time and space
Johanna Klughammer, Barbara Kiesel, Thomas Roetzer-Pejrimovsky, et al.
Nature Medicine (2018) Vol. 24, Iss. 10, pp. 1611-1624
Open Access | Times Cited: 255
Johanna Klughammer, Barbara Kiesel, Thomas Roetzer-Pejrimovsky, et al.
Nature Medicine (2018) Vol. 24, Iss. 10, pp. 1611-1624
Open Access | Times Cited: 255
DNA methylation heterogeneity defines a disease spectrum in Ewing sarcoma
Nathan C. Sheffield, Gaëlle Pierron, Johanna Klughammer, et al.
Nature Medicine (2017) Vol. 23, Iss. 3, pp. 386-395
Open Access | Times Cited: 226
Nathan C. Sheffield, Gaëlle Pierron, Johanna Klughammer, et al.
Nature Medicine (2017) Vol. 23, Iss. 3, pp. 386-395
Open Access | Times Cited: 226
Measurable residual disease testing in acute myeloid leukaemia
Christopher S. Hourigan, Robert Peter Gale, Nicole Gormley, et al.
Leukemia (2017) Vol. 31, Iss. 7, pp. 1482-1490
Closed Access | Times Cited: 213
Christopher S. Hourigan, Robert Peter Gale, Nicole Gormley, et al.
Leukemia (2017) Vol. 31, Iss. 7, pp. 1482-1490
Closed Access | Times Cited: 213
Endogenous retroviral promoter exaptation in human cancer
Artem Babaian, Dixie L. Mager
Mobile DNA (2016) Vol. 7, Iss. 1
Open Access | Times Cited: 211
Artem Babaian, Dixie L. Mager
Mobile DNA (2016) Vol. 7, Iss. 1
Open Access | Times Cited: 211
A cellular hierarchy framework for understanding heterogeneity and predicting drug response in acute myeloid leukemia
Andy G.X. Zeng, Suraj Bansal, Liqing Jin, et al.
Nature Medicine (2022) Vol. 28, Iss. 6, pp. 1212-1223
Open Access | Times Cited: 197
Andy G.X. Zeng, Suraj Bansal, Liqing Jin, et al.
Nature Medicine (2022) Vol. 28, Iss. 6, pp. 1212-1223
Open Access | Times Cited: 197
Clonal heterogeneity of acute myeloid leukemia treated with the IDH2 inhibitor enasidenib
Lynn Quek, Muriel D. David, Alison Kennedy, et al.
Nature Medicine (2018) Vol. 24, Iss. 8, pp. 1167-1177
Open Access | Times Cited: 180
Lynn Quek, Muriel D. David, Alison Kennedy, et al.
Nature Medicine (2018) Vol. 24, Iss. 8, pp. 1167-1177
Open Access | Times Cited: 180
Chemotherapy Induces Senescence-Like Resilient Cells Capable of Initiating AML Recurrence
Cihangir Duy, Meng Li, Matt Teater, et al.
Cancer Discovery (2021) Vol. 11, Iss. 6, pp. 1542-1561
Open Access | Times Cited: 177
Cihangir Duy, Meng Li, Matt Teater, et al.
Cancer Discovery (2021) Vol. 11, Iss. 6, pp. 1542-1561
Open Access | Times Cited: 177
CancerDetector: ultrasensitive and non-invasive cancer detection at the resolution of individual reads using cell-free DNA methylation sequencing data
Wenyuan Li, Qingjiao Li, Shuli Kang, et al.
Nucleic Acids Research (2018) Vol. 46, Iss. 15, pp. e89-e89
Open Access | Times Cited: 167
Wenyuan Li, Qingjiao Li, Shuli Kang, et al.
Nucleic Acids Research (2018) Vol. 46, Iss. 15, pp. e89-e89
Open Access | Times Cited: 167
Epigenetics as a mediator of plasticity in cancer
Andrew P. Feinberg, Andre Levchenko
Science (2023) Vol. 379, Iss. 6632
Open Access | Times Cited: 164
Andrew P. Feinberg, Andre Levchenko
Science (2023) Vol. 379, Iss. 6632
Open Access | Times Cited: 164